Next, we separately analyzed the relationships between the drug sensitivity of tumor cells of patients with primary AML and the expression of lymphoid (T- and B-) and immature markers as well as the proliferation marker, Ki-67, which are indicators of an unfavorable prognosis for leukemia [39,40,41,42]. This evidence concerns the gene MKI67 and acute myeloid leukemia.